ACTIVE BIOTECH AB

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 22233
 
  
 
C07D HETEROCYCLIC COMPOUNDS 17145
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 643
 
  
 
C07K PEPTIDES 4132
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1205

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9873687 N-(heteroaryl)-sulfonamide derivatives useful as S100-inhibitorsMay 14, 14Jan 23, 18[C07D]
9771372 Compounds useful as S100-inhibitorsMay 22, 15Sep 26, 17[C07D]
9216956 Deuterium-enriched 4-hydroxy-5-methoxy-N,1-dimethyl-2-oxo-N-[(4-trifluoro-methyl)phenyl]-1,2-dihydroquinoline-3-carboxamideJun 20, 12Dec 22, 15[A61K, C07D]
8871936 Method for manufacturing of quinoline-3-carboxamidesJul 07, 11Oct 28, 14[C07D]
8841421 S100A9 interaction screening methodApr 24, 08Sep 23, 14[G01N, C07K]
8754104 Crystalline salts of quinoline compounds and methods for preparing themNov 06, 12Jun 17, 14[A61K]
8545885 Stable laquinimod preparationsMay 14, 12Oct 01, 13[A61K]
8314124 Crystalline salts of quinoline compounds and methods for preparing themMar 17, 09Nov 20, 12[A61K, C07D]
8293243 Treatment of hyperproliferative disease with superantigens in combination with another anticancer agentMay 25, 10Oct 23, 12[A61K]
7763253 Treatment of hyperproliferative disease with superantigens in combination with another anticancer agentAug 12, 05Jul 27, 10[A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2010/0111,978 CONJUGATES BETWEEN A VARIANT STAPHYLOCOCCAL ENTEROTOXIN E SUPERANTIGEN AND A TARGETING ANTIBODY THAT BINDS TO A CANCER-ASSOCIATED CELL SURFACE STRUCTUREAbandonedSep 28, 09May 06, 10[A61K, A61P, C07K]
2009/0118,330 Diurea derivativesAbandonedJan 19, 05May 07, 09[A61K, C07D, A61P]
7511143 Compositions containing quinoline compoundsWithdrawnFeb 04, 05Mar 31, 09[C07D]
7425623 Antibody with specificity for colon cancerExpiredFeb 23, 01Sep 16, 08[C07K]
2008/0119,485 Novel Benzofurans and IndolsAbandonedJan 23, 08May 22, 08[A61K, C07D, A61P]
7339059 Benzofurans and indolsExpiredNov 23, 04Mar 04, 08[C07D]
2007/0112,179 Novel compoundsAbandonedNov 08, 06May 17, 07[A61K, C07K]
2006/0062,795 Conjugate between a modified superantigen and a target-seeking compound and the use of the conjugateAbandonedJul 29, 05Mar 23, 06[A61K, C07K]
2005/0260,215 Conjugate between a modified superantigen and a target-seeking compound and the use of the conjugateAbandonedJul 29, 05Nov 24, 05[A61K, C07K]
6962694 Cytolysis of target cells by superantigen conjugates inducing T-cell activationExpiredJul 21, 98Nov 08, 05[A61K]
2005/0226,885 Cytolysis of target cells by superantigen conjugates inducing T-cell activationAbandonedDec 27, 04Oct 13, 05[A61K]
2005/0192,289 Novel cinnamic amidesAbandonedNov 23, 04Sep 01, 05[A61K]
2004/0146,531 Virus-like particles devoid of HPV 16 type-specific antibody epitopes as carriers of peptides for introduction into cellsAbandonedJan 20, 04Jul 29, 04[A61K, C12N]
2004/0106,160 Screening assay for antagonists of human leukocyte receptorsAbandonedJun 20, 03Jun 03, 04[C12Q, G01N]
6727062 Identification of target structures E.G. in vivo selection method for a phage libraryExpiredJul 30, 99Apr 27, 04[C12Q, C12P, G01N, C07K]
2002/0173,520 Quinoline derivativesAbandonedApr 25, 02Nov 21, 02[A61K, C07D]
6197299 Antibody conjugatesExpiredSep 16, 98Mar 06, 01[A61K, C07K]
4738971 N-aryl-1,2-dihydro-4-substituted-1-alkyl-2-oxo-quinoline-3-carboxamidesExpiredApr 16, 85Apr 19, 88[A61K, C07D]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.